Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Jun 3, 2013
Insider Transaction Report
Form 4
POWER ROBERT N
Director
Transactions
- Disposition to Issuer
Deferred Share Units
2013-05-30$90.81/sh+31,202$2,833,454→ 0 totalExercise: $0.00→ Common Shares, no par value (31,202 underlying) - Disposition to Issuer
Common Stock, no par value
2013-05-30$90.81/sh−4,397$399,292→ 13,084 total
Footnotes (2)
- [F1]On May 30, 2012, upon recommendation of the Nominating and Corporate Governance Committee, the Board determined that it was in the Company's best interest to terminate the equity program of the Mandatory Share Units (other units granted prior to October 3, 2004) and to be delivered in 2013 pursuant to the plan termination rules under Code Section 409A. This number represents Mandatory Share Units disposed of for a cash payment in lieu of receiving common shares.
- [F2]This number represents common shares purchased and other equity awards that were previously reported in Table 1.